DK0799039T3 - Anvendelse af antivirale aminopurin-præparater til behandling og profylakse af latente herpesvirus infektioner - Google Patents

Anvendelse af antivirale aminopurin-præparater til behandling og profylakse af latente herpesvirus infektioner

Info

Publication number
DK0799039T3
DK0799039T3 DK95941044T DK95941044T DK0799039T3 DK 0799039 T3 DK0799039 T3 DK 0799039T3 DK 95941044 T DK95941044 T DK 95941044T DK 95941044 T DK95941044 T DK 95941044T DK 0799039 T3 DK0799039 T3 DK 0799039T3
Authority
DK
Denmark
Prior art keywords
aminopurine
prophylaxis
antiviral
preparations
treatment
Prior art date
Application number
DK95941044T
Other languages
Danish (da)
English (en)
Inventor
Hugh John Field
Alana Maureen Thackray
Teresa Helen Bacon
David Sutton
Hodge Richard Anthony Vere
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451235&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0799039(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9425012.3A external-priority patent/GB9425012D0/en
Priority claimed from GBGB9506663.5A external-priority patent/GB9506663D0/en
Priority claimed from GBGB9517308.4A external-priority patent/GB9517308D0/en
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Application granted granted Critical
Publication of DK0799039T3 publication Critical patent/DK0799039T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95941044T 1994-12-12 1995-11-23 Anvendelse af antivirale aminopurin-præparater til behandling og profylakse af latente herpesvirus infektioner DK0799039T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9425012.3A GB9425012D0 (en) 1994-12-12 1994-12-12 Pharmaceuticals
GBGB9506663.5A GB9506663D0 (en) 1995-03-31 1995-03-31 Pharmaceuticals
GBGB9517308.4A GB9517308D0 (en) 1995-08-24 1995-08-24 Pharmaceuticals
US08/522,790 US5840763A (en) 1994-12-12 1995-09-01 Treatment of a latent infection of herpes viruses
PCT/EP1995/004692 WO1996018396A1 (en) 1994-12-12 1995-11-23 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections

Publications (1)

Publication Number Publication Date
DK0799039T3 true DK0799039T3 (da) 2002-01-28

Family

ID=27451235

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95941044T DK0799039T3 (da) 1994-12-12 1995-11-23 Anvendelse af antivirale aminopurin-præparater til behandling og profylakse af latente herpesvirus infektioner

Country Status (24)

Country Link
US (2) US5840763A (de)
EP (1) EP0799039B1 (de)
JP (1) JP2008088189A (de)
CN (1) CN1098687C (de)
AP (1) AP669A (de)
AT (1) ATE208198T1 (de)
AU (1) AU699627B2 (de)
BG (1) BG63815B1 (de)
BR (1) BR9509986A (de)
CA (1) CA2207503C (de)
CY (1) CY2339B1 (de)
CZ (1) CZ291545B6 (de)
DE (1) DE69523776T2 (de)
DK (1) DK0799039T3 (de)
ES (1) ES2166834T3 (de)
HK (1) HK1003259A1 (de)
HU (1) HU222835B1 (de)
NO (1) NO313862B1 (de)
NZ (1) NZ297424A (de)
PT (1) PT799039E (de)
RO (1) RO120042B1 (de)
SI (1) SI0799039T1 (de)
SK (1) SK282983B6 (de)
WO (1) WO1996018396A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
US6047209A (en) * 1999-04-02 2000-04-04 Denny; Jeffrey Paul Method and apparatus for maintenance of pierced orifices
CA2602691A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
EP3753563A1 (de) * 2019-06-20 2020-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Guanosinanalog gegen herpesvirus zur hemmung der basalen autophagie

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
EP0141927B1 (de) * 1983-08-18 1991-10-30 Beecham Group Plc Antivirale Guanin-Derivate
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses

Also Published As

Publication number Publication date
SK75197A3 (en) 1997-11-05
SI0799039T1 (en) 2002-06-30
RO120042B1 (ro) 2005-08-30
DE69523776D1 (de) 2001-12-13
BR9509986A (pt) 1997-11-25
BG101608A (en) 1998-02-27
HU222835B1 (hu) 2003-11-28
CZ291545B6 (cs) 2003-04-16
ATE208198T1 (de) 2001-11-15
PT799039E (pt) 2002-04-29
SK282983B6 (sk) 2003-01-09
CN1175212A (zh) 1998-03-04
AU4257896A (en) 1996-07-03
JP2008088189A (ja) 2008-04-17
BG63815B1 (bg) 2003-02-28
DE69523776T2 (de) 2002-08-01
AP9701001A0 (en) 1997-07-31
WO1996018396A1 (en) 1996-06-20
NO313862B1 (no) 2002-12-16
NO972688D0 (no) 1997-06-11
CA2207503A1 (en) 1996-06-20
HUT77437A (hu) 1998-04-28
EP0799039A1 (de) 1997-10-08
CA2207503C (en) 2006-07-18
CZ179997A3 (en) 1997-09-17
CY2339B1 (en) 2004-02-06
EP0799039B1 (de) 2001-11-07
AP669A (en) 1998-09-04
US5840763A (en) 1998-11-24
NZ297424A (en) 2000-07-28
NO972688L (no) 1997-08-07
AU699627B2 (en) 1998-12-10
ES2166834T3 (es) 2002-05-01
MX9704336A (es) 1997-09-30
US5916893A (en) 1999-06-29
CN1098687C (zh) 2003-01-15
HK1003259A1 (en) 1998-10-23

Similar Documents

Publication Publication Date Title
PT769965E (pt) Formulacoes aquosas de risperidona
DK0660689T3 (da) Osteosyntesehjælpemiddel
NO942196D0 (no) Fluorenforbindelser og fremgangsmåte for deres fremstilling
ID21948A (id) Penggunaan 1-hidroksi-2piridon untuk pengobatan infeksi-infeksi kulit
NO995622D0 (no) Karbocyklisk nukleosidhemisulfat og anvendelse derav for behandling av virale infeksjoner
GB9304746D0 (en) Treatment of viral infections
DK0799039T3 (da) Anvendelse af antivirale aminopurin-præparater til behandling og profylakse af latente herpesvirus infektioner
DK0538305T3 (da) Penciclovir og famciclovir og beslægtede guaninderivater til behandling af HIV-1-infektioner
AU6748090A (en) Use of caffeine in the treatment of herpes simplex virus infections
NO983402L (no) Nukeosidanaloger i kombinasjonsterapi av herpes simplex infeksjoner
EP0546261A3 (en) Method of treating latent herpes viral infections
DK0689577T3 (da) Anvendelse af ferroncen
PT804199E (pt) Uso de penciclovir para o tratamento de nevralgias pos-herpeticas
ITMI913464A0 (it) Procedimento per la neutralizzazione di perfluoropolissialchileni
EP0655919A4 (de) Behandlung von virusinfektionen beim menschen.
FI954348A (fi) Säädetysti vapauttava alumiinia sisältävä farmaseuttinen valmiste
ZA941471B (en) Treatment of viral infections
ATA19993A (de) Krücke
KR940000380U (ko) 자궁거상용 겸자
DE69228885D1 (de) Kondom
FI934388A0 (fi) Multifokal kontaktlins med avvikande styrka pao baksidan
BG52099B2 (en) Gel for the treatment of skin viral infections
KR940025936U (ko) 허리사이즈 조절식 팬티
NO930605D0 (no) Hjelpemiddel ved kalving
GB9422923D0 (en) Treatment of viral infections